Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.1.1.u2
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ (3,977) $ (6,432)
General and administrative (2,186) (2,098)
Total operating expenses (6,163) (8,530)
Operating loss (6,163) (8,530)
Interest expense, net (487) (399)
Adjustments to fair value of derivatives (386) (878)
Other (expense) / income, net (17) 41
Total other expense (890) (1,236)
Loss before income taxes (7,053) (9,766)
Income tax expense (48) (123)
Net loss $ (7,101) $ (9,889)
Net loss per share - basic $ (0.46) $ (0.78)
Net loss per share - diluted $ (0.46) $ (0.78)
Weighted average ordinary shares outstanding - basic 15,432,693 12,681,900
Weighted average ordinary shares outstanding - diluted 15,432,693 12,681,900
Statements of Comprehensive Loss    
Net loss $ (7,101) $ (9,889)
Unrealized (loss) / gain on marketable securities (1) 219
Comprehensive loss $ (7,102) $ (9,670)